FERRARA, VIVIANA
 Distribuzione geografica
Continente #
NA - Nord America 354
EU - Europa 177
AS - Asia 93
AF - Africa 65
SA - Sud America 36
Totale 725
Nazione #
US - Stati Uniti d'America 349
IT - Italia 105
SG - Singapore 61
IE - Irlanda 41
BR - Brasile 34
CI - Costa d'Avorio 32
SN - Senegal 23
CN - Cina 20
DE - Germania 12
NG - Nigeria 6
CA - Canada 5
SE - Svezia 5
UZ - Uzbekistan 4
MA - Marocco 3
RU - Federazione Russa 3
TR - Turchia 3
FI - Finlandia 2
NL - Olanda 2
UA - Ucraina 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
CL - Cile 1
FR - Francia 1
GB - Regno Unito 1
IN - India 1
KE - Kenya 1
MK - Macedonia 1
PK - Pakistan 1
Totale 725
Città #
Chandler 92
Santa Clara 87
Dublin 41
Singapore 40
Chicago 37
Abidjan 32
Dakar 23
Civitanova Marche 19
Boardman 14
Catania 12
Cambridge 11
Lawrence 11
Andover 10
Carrara 7
Des Moines 7
Abuja 6
Nanjing 6
Padova 6
Bremen 5
Los Angeles 4
Ashburn 3
Leawood 3
Milan 3
Rome 3
Tashkent 3
Wilmington 3
Beijing 2
Contagem 2
Council Bluffs 2
Dong Ket 2
Florianópolis 2
Frankfurt Am Main 2
Houston 2
Messina 2
Munich 2
Ottawa 2
Salvador 2
Shenzhen 2
São Bernardo do Campo 2
Adrano 1
Almirante Tamandaré 1
Alvorada 1
Amsterdam 1
Araraquara 1
Araras 1
Arezzo 1
Baixo Guandu 1
Barbacena 1
Belo Horizonte 1
Belo Jardim 1
Betim 1
Cachoeiro de Itapemirim 1
Casablanca 1
Chengdu 1
Civitavecchia 1
Concórdia 1
Curitiba 1
Esteio 1
Helsinki 1
Iguatu 1
Irkutsk 1
Istanbul 1
Itaquaquecetuba 1
Itápolis 1
Jacksonville 1
Jiaxing 1
Kayseri 1
Laayoune 1
Lages 1
Lahore 1
Lappeenranta 1
Luhansk 1
Manaus 1
Marcionílio Souza 1
Melzo 1
Modica 1
Mumbai 1
Nairobi 1
Naples 1
Newbury Park 1
Nocera Inferiore 1
Oujda 1
Palermo 1
Phoenix 1
Presidente Epitácio 1
Reggio Emilia 1
San Francisco 1
Santiago 1
Seattle 1
Seregno 1
Sharjah 1
Simões Filho 1
São Gonçalo 1
São João 1
São Luís 1
São Paulo 1
Tappahannock 1
Tirana 1
Toronto 1
Volta Redonda 1
Totale 575
Nome #
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 91
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 74
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 73
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 71
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 71
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 64
Left ventricular geometry and periodontitis in patients with the metabolic syndrome 57
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 55
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units 55
Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile 54
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 52
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units 39
Totale 756
Categoria #
all - tutte 3.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/202131 0 2 0 0 3 1 0 0 2 15 6 2
2021/2022111 3 5 1 12 20 8 21 7 3 2 3 26
2022/2023217 13 22 5 29 19 34 1 44 35 1 7 7
2023/202472 4 17 5 2 1 19 1 3 1 3 9 7
2024/2025300 3 58 13 29 68 46 27 10 20 25 1 0
Totale 756